1.Park JW: Hepatocellular carcinoma in Korea: introduction and overview.
Korean J Gastroenterol 2005; 45: 217-26.
2.Parkin DM,
Bray F,
Ferlay J,
et al: Global cancer statistics 2002.
CA Cancer J Clin 55:74-108,2005
3.Lai EC,
Fan ST,
Lo CM,
Chu KM,
Liu CL,
Wong J: Hepatic resection for hepatocellular carcinoma: an audit of 343 patients.
Ann Surg 1995; 221: 291-8.
4.Lo CM,
Ngan H,
Tso WK,
Liu CL,
Lam CM,
Poon RT,
et al.: Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma.
Hepatology 2002; 35: 1164-71.
5.Kurokohchi K,
Hirai S,
Ohgi T,
Ono M,
Yoshitake A,
Ebara K,
et al.: Thoracoscopic ethanol injectin and radiofrequency ablation for the treatment of heapatocellular carcinoma located immediately under the diaphragm.
Int JOncol 2006; 29: 375-80.
6.Mulier S,
Ni Y,
Jamart J,
Ruers T,
Marchal G,
Michel L: Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors.
Ann Surg 2005; 242: 158-71.
7.Okuda K,
Ohtsuki T,
Obata H,
Tomimatsu M,
Okazaki N,
Hasegawa H,
et al.: Natural history of hepatocellular carcinoma and prognosis in relation to treatment: Study of 850 patients.
Cancer 1985; 56: 918-28.
8.
Bruix J,
Llovet JM: Prognostic prediction and treatment strategy in hepatocellular carcinoma.
Hepatology 2002; 35: 519-24.
9.McGahan JP,
Browning PD,
Brock JM,
Tesluk H: Hepatic ablation using radiofrequency electrocautery.
Invest Radiol 1990; 25: 267-70.
10.Liem MS,
Poon RT,
Lo CM,
Tso WK,
Fan ST: Outcome of transarterial chemoembolization in patients with inoperable hepatocellular carcinoma eligible for radiofrequency ablation.
World J Gastroenterol 2005; 11: 4465-71.
11.Teratani T,
Yoshida H,
Shiina S,
Obi S,
Sato S,
Tateishi R,
et al.: Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locations.
Hepatology 2006; 43: 1101-8.
12.Lencioni RA,
Allgaier HP,
Cioni D,
Olschewski M,
Deipert P,
Crocetti L,
et al.: Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection.
Radiology 2003; 228: 235-40.
13.Rhim H,
Yoon K,
Lee J,
Cho Y,
Cho J,
Kim S,
et al.: Major complications after radio-frequency thermal ablation of hepatic tumors: spectrum of imaging findings.
RadioGraphics 2003; 23: 123-34.
14.Buscarini L,
Buscarini E,
Di Stasi M,
Vallisa D,
Quaretti P,
Rocca A: Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results.
Eur Radiol 2001; 11: 914-21.
15.Livraghi T,
Lazzaroni S,
Meloni F: Radiofrequency ablation of hepatocellular carcinoma.
Eur J Ultrasound 2001; 13: 159-66.
16.Goldberg SN,
Hahn PF,
Halpern EF,
Fogle RM,
Gazelle GS: Radiofrequency tissue ablation: effect of pharmacologic modulation of blood flow on coagulation diameter.
Radiology 1998; 209: 761-7.
17.Livraghi T,
Goldberg SN,
Lazzaroni S,
Meloni F,
Solbiati L,
Gazelle GS: Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection.
Radiology 1999; 210: 655-61.
18.Kurokohchi K,
Watanabe S,
Masaki T,
Hosonomi N,
Funaki T,
Arima K,
et al.: Combined use of percutaneous ethanol injection and radiofrequency ablation for the effective treatment of hepatocellular carcinoma.
Int J Oncol 2002; 21: 841-6.
19.Shiina S,
Tagawa K,
Unuma T,
Takanashi R,
Yoshiura K,
Komatsu Y,
et al.: Percutaneous ethanol injection therapy for hepatocellular carcinoma: a histopathologic study.
Cancer 1991; 68: 1524-30.
20.Wong SN,
Lin CJ,
Lin CC,
Chen WT,
Cua IH,
Lin SM: Combined percutaneous radiofrequency ablation and ethanol injection for hepatocellular carcinoma in high-risk locations.
Am J Roentgenol 2008; 190: 187-95.
21.Zhang YJ,
Liang HH,
Chen MS,
Guo RP,
Li JQ,
Zheng Y,
et al.: Hepatocellular carcinoma treated with radiofrequency ablation with or without ethnalol injection: a prospective randomized trial.
Radiology 2007; 244: 599-607.